# Moxonidine for Prevention of Post-ablation AFib Recurrences

Study · id `cardio:ct-nct01791699` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01791699](<https://clinicaltrials.gov/study/NCT01791699>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01791699

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 150 participants.

## Technical summary

Registry record NCT01791699. Randomized; quadruple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT01791699, source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01791699, source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)
- Primary completion: 2013-11 (actual) (ClinicalTrials.gov record NCT01791699, source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)
- Completion: 2014-04 (actual) (ClinicalTrials.gov record NCT01791699, source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)
- Countries: Greece (ClinicalTrials.gov record NCT01791699, source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01791699-2014-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Moxonidine for Prevention of Post-ablation AFib Recurrences
- Condition: Atrial Fibrillation
- Intervention (Drug): Moxonidine
- Intervention (Drug): Placebo
- Lead sponsor: Spyridon Deftereos
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study (`cardio:pubmed-25147079`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation (`cardio:pubmed-25847478`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Postablation Statin Treatment on Arrhythmia Recurrence in Patients With Paroxysmal Atrial Fibrillation (`cardio:pubmed-30520854`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4cd45a6faedcc1f1a68c1aae9326b30b77bdfab226fa07455c66ca64717da94f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
